Competitive intelligence on
small-molecule drugs and
the 80,000 global patents
covering them

Start your free trial now

No commitment — No credit card required

DrugPatentWatch Ultimate Plan Preview

Profile for Tradename: NASONEX

« Back to Dashboard

Summary for Tradename: NASONEX

Patents:3
Applicants:1
NDAs:1
Suppliers: see list3
2013 Sales:$1,137,402,000

Pharmacology for Tradename: NASONEX

Clinical Trials for: NASONEX

Bronchodilatory Efficacy of a Single Dose QMF149 (Indacaterol Maleate/Mometasone Furoate) Via the Twisthaler® Device in Adult Patients With Asthma
Status: Completed Condition: Asthma

Placebo-controlled Trial With Nasonex for Nasal Obstruction Secondary to Adenoids Hypertrophy in Children (P04367)(TERMINATED)
Status: Terminated Condition: Nasal Obstruction; Adenoids Hypertrophy; Adenoidectomy

Intranasal Mometasone in Children With Obstructive Sleep Apnea Due to Adenotonsillar Hypertrophy
Status: Not yet recruiting Condition: Obstructive Sleep Apnea (Mild, Moderate, Severe) as Per Polysomnography

A Study of Mometasone Furoate Nasal Spray in Perennial Allergic Rhinitis (Study P03748)(COMPLETED)
Status: Completed Condition: Rhinitis, Allergic, Perennial

A Comparative Study of Mometasone Furoate Nasal Spray and Fluticasone Propionate Nasal Spray in Patients With Perennial Allergic Rhinitis (Study P04512)
Status: Completed Condition: Perennial Allergic Rhinitis

Acute Effect of Mometasone Furoate DPI on Beta-adrenergic Airway and Airway Vascular Relaxation in Moderately Severe Asthma
Status: Not yet recruiting Condition: Asthma

An Exploratory Study of Nasonex in Patients With Moderate to Severe Persistent Allergic Rhinitis and Intermittent Asthma
Status: Completed Condition: Allergic Rhinitis; Asthma

Asthma Study Comparing Anti-Inflammatory Effects of 3 Doses of Mometasone Furoate/Formoterol Fumarate and Medium Dose Mometasone Furoate (Study P05122 AM1)(COMPLETED)
Status: Completed Condition: Asthma; Airway Inflammation

Single Dose Crossover Study of Patient Preference for Unscented Nasonex® Nasal Spray Versus Scented Flonase® Nasal Spray (Study P04207)
Status: Completed Condition: Allergic Rhinitis

Single Dose Crossover Study of Patient Preference for Unscented Nasonex® Nasal Spray Versus Scented Flonase® Nasal Spray (Study P04208)
Status: Completed Condition: Allergic Rhinitis

Courtesy of ClinicalTrials.org
See more clinical trials for this drug
Glossary
Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Merck Sharp Dohme
NASONEX
mometasone furoate monohydrate
SPRAY, METERED;NASAL020762Oct 1, 1997RXYes5,837,699*PED<disabled>Y<disabled>
Merck Sharp Dohme
NASONEX
mometasone furoate monohydrate
SPRAY, METERED;NASAL020762Oct 1, 1997RXYes6,723,713*PED<disabled>Y<disabled>
Merck Sharp Dohme
NASONEX
mometasone furoate monohydrate
SPRAY, METERED;NASAL020762Oct 1, 1997RXYes6,127,353*PED<disabled>Y<disabled>
Merck Sharp Dohme
NASONEX
mometasone furoate monohydrate
SPRAY, METERED;NASAL020762Oct 1, 1997RXYes<disabled><disabled>
This preview shows a limited data set
Subscribe for full access , or try a free trial

Export unavailable in trial.
Subscribe for complete access.

Paragraph IV activity for: NASONEX

Drugname Dosage Strength RLD Submissiondate
mometasone furoateNasal Spray50 mcg/ SprayNasonex8/7/2009
« Back to Dashboard

DrugPatentWatch Archives

You are viewing the current data set
Select a link below to view the archives:

 2000   2001   2002   2003   2004   2005   2006   2007   2008   2009   2010   2011   2012   2013  

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.

Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Connect with Social Media:

Follow DrugPatentWatch on Twitter Connect with DrugPatentWatch on Linkedin Drug Patents on LinkedIn

Copyright © 2002-2014 thinkBiotech LLC. ISSN: 2162-2639

Other thinkBiotech sites: PatentStatBiotechBlogJournal of Commercial Biotechnology

`abc